The Defiant·
Isomorphic Labs Raises $5 Billion for AI Drug Design

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.
Every crypto headline. One feed. Updated every minute.

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.